Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Acta Neurologica Belgica
Published in: Acta Neurologica Belgica 3/2018

01-09-2018 | Original Article

Association of interleukin 6, interleukin 7 receptor alpha, and interleukin 12B gene polymorphisms with multiple sclerosis

Authors: Yvonne Benešová, Anna Vašků, Julie Bienertová-Vašků

Published in: Acta Neurologica Belgica | Issue 3/2018

Login to get access

Abstract

Pro-inflammatory and anti-inflammatory cytokines have been shown to play a crucial role in the pathophysiology of multiple sclerosis (MS). We investigated the association between interleukin (IL) IL6-174 G/C (rs1800795), IL7RA C/T (rs6897932), and IL-12B A1188C (rs3212227) gene polymorphisms (SNPs) and MS. The study consisted of 297 unrelated MS patients and 135 healthy individuals. In IL6-174G/C (rs1800795), a significant association between the C allele and MS risk [OR 1.41, 95% CI (1.05–1.92); P = 0.025] was found. Carriage of genotypes CC and CG were more common in MS patients [OR 1.58, 95% CI (1.04–2.39); P = 0.031] and also in female MS patients [OR 1.68, 95% CI (1.02–2.79); P = 0.043]. However, after applying Bonferroni’s correction the differences did not remain significant. No significant association between the IL7RA C/T (rs6897932) and IL12B A1188C (rs3212227) gene polymorphisms and MS susceptibility was observed. Regarding IL-12B A1188C (rs3212227), a significant association between the CC genotype and MS progression, expressed as MSSS, was demonstrated in the female MS group. Our results indicate that the distribution of IL6-174G/C (rs1800795) SNP was marginally associated with MS susceptibility. We also showed that IL-12B A1188C (rs3212227) can contribute to the progression of the disease in the Czech population.
Appendix
Available only for authorised users
Literature
1.
Hartung H, Bar-Or A, Zoukos Y (2004) What do we know about the mechanism of action of disease modifying treatments in MS? J Neurol 251:v12–v19CrossRefPubMed
2.
Trapp BD, Nave KA (2008) Multiple sclerosis: an immune or neurodegenerative disorder? Ann Rev Neurosci 31:247–269CrossRefPubMed
3.
Hauser SL, Goodin DS (2012) Multiple sclerosis and other demyelinating diseases. In: Longo DL, Fauci SA, Kasper DL et al. (eds) Harrison’s principle of internal medicine, vol 18. McGraw-Hill, New York
4.
McFarland HF, Martin R (2007) Multiple sclerosis: a complicated picture of autoimmunity. Nat Immunol 8(9):913–919CrossRefPubMed
5.
6.
International Multiple Sclerosis Genetics Consortium, Wellcome Trust Case Control Consortium 2, Sawcer S, Hellenthal G, Pirinen M et al (2011) Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476:214–219CrossRef
7.
International Multiple Sclerosis Genetics Consortium (IMSGC), Wellcome Trust Case Control Consortium 2 (WTCCC2), International IBD Genetics Consortium (IIBDGC), Beecham AH et al (2013) Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet 45:1353–1360CrossRef
8.
Jadidi-Niaragh F, Mirshafiey A (2011) Th17 cell, the new player of neuroinflammatory process in multiple sclerosis. Scand J Immunol 74:1–13CrossRefPubMed
9.
Pittock SJ, Lucchinetti CF (2007) The pathology of MS: new insights and potential clinical applications. Neurologist 13:45–56CrossRefPubMed
10.
11.
Del Vecchio M, Bajetta E, Canova S et al (2007) Interleukin-12: biological properties and clinical application. Clin Cancer Res 13:4677–4685CrossRefPubMed
12.
Trinchieri G (2003) Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3:133–146CrossRefPubMed
13.
14.
Liu Z, Yadav PK, Xu X et al (2011) The increased expression of IL-23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity. J Leukoc Biol 89:597–606CrossRefPubMed
15.
Zheng Y, Wang M, Tian T et al (2017) Role of interleukin-12 gene polymorphisms in the onset risk of cancer: a meta-analysis. Oncotarget 2:29795–29807
16.
Sun L, He C, Nair L et al (2015) Interleukin 12 (IL-12) family cytokines: role in immune pathogenesis and treatment of CNS autoimmune disease. Cytokine 75:249–255CrossRefPubMedPubMedCentral
17.
Tsunemi Y, Saeki H, Nakamura K et al (2002) Interleukin-12 p40 gene (IL12B) 3′-untranslated region polymorphism is associated with susceptibility to atopic dermatitis and psoriasis vulgaris. J Dermatol Sci 30:161–166CrossRefPubMed
18.
Wang EY, Yang Q, Liao ZG (2015) Association of polymorphisms in interleukin (IL)-12A and -B genes with rheumatoid arthritis in a Chinese population. Clin Exp Immunol 180:83–89CrossRefPubMedPubMedCentral
19.
20.
Gocket AR, Cravens PD, Ben LH et al (2007) T-bet regulaetes the fate of Th1 and Th17 lymphocytes in autoimmunity. J Immunol 178:1341–1348CrossRef
21.
22.
Frausto RF et al (2009) Site-specific production of IL-6 in the central nervous system retargets and enhances the inflammatory response in experimental autoimmune encephalomyelitis. J Immunol 183:2079–2088CrossRefPubMed
23.
Rivera-Chavez FA, Peters-Hybki DL, Barber RC, O’Keefe GE (2003) Interleukin-6 promoter haplotypes and interleukin-6 cytokine responses. Shock 20:218–223CrossRefPubMedPubMedCentral
24.
Slattery ML, Wolff RK, Curtin K et al (2009) Colon tumor mutations and epigenetic changes associated with genetic polymorphism: insight into disease pathways. Mutat Res 660:12–21CrossRefPubMed
25.
Tartter M, Hammen C, Bower JE et al (2015) Effects of chronic interpersonal stress exposure on depressive symptoms are moderated by genetic variation at IL6 and IL1β in youth. Brain Behav Immun 46:104–111CrossRefPubMedPubMedCentral
26.
Chumaeva N, Hintsanen M, Pulkki-Råback L et al (2014) Interleukin-6 gene polymorphism, chronic stress and atherosclerosis: interleukin-6-174G/C polymorphism, chronic stress and risk of early atherosclerosis in the Cardiovascular Risk in Young Finns study. Psychosom Res 76:333–338CrossRef
27.
Ururahy MA, de Souza KS, Oliveira YM et al (2015) Association of polymorphisms in IL6 gene promoter region with type 1 diabetes and increased albumin-to-creatinine ratio. Diabetes Metab Res Rev 31:500–506CrossRefPubMed
28.
29.
Mirowska-Guzel D, Gromadzka G, Mach A et al (2011) Association of IL1A, IL1B, ILRN, IL6, IL10 and TNF-α polymorphisms with risk and clinical course of multiple sclerosis in a Polish population. J Neuroimmunol 236:87–92CrossRefPubMed
30.
Ye SK, Agata Y, Lee HC et al (2001) The IL-7 receptor controls the accessibility of the TCRgamma locus by Stat5 and histone acetylation. Immunity 15(5):813–823CrossRefPubMed
31.
Gregory SG, Schmidt S, Seth P, et al, Multiple Sclerosis Genetics Group (2007) Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat Genet 39:1083–1091CrossRefPubMed
32.
Liu H, Huang J, Dou M et al (2017) Variants in the IL7RA gene confer susceptibility to multiple sclerosis in Caucasians: evidence based on 9734 cases and 10436 controls. Sci Rep 26:1207CrossRef
33.
Tavakolpour S, Rahimzadeh G (2016) Interleukin 7 receptor polymorphisms and the risk of multiple sclerosis: a meta-analysis. Scand J Immunol 84:146–149CrossRefPubMed
34.
Akkad DA, Hoffjan S, Petrasch-Parwez E et al (2009) Variation in the IL7RA and IL2RA genes in German multiple sclerosis patients. J Autoimmun 32:110–115CrossRefPubMed
35.
Lundmark F, Duvefelt K, Iacobaeus E et al (2007) Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. Nat Genet 39:1108–1113CrossRefPubMed
36.
37.
Polman CH, Reingold SC, Banwell B et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69:292–302CrossRefPubMedPubMedCentral
38.
Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 33:1444–1452CrossRefPubMed
39.
Roxburgh RH, Seaman SR, Masterman T et al (2005) Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology 64:1144–1151CrossRefPubMed
40.
International Multiple Sclerosis Genetics Consortium, Hafler DA et al (2007) Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 357:851–862CrossRef
41.
Nicot A (2009) Gender and sex hormones in multiple sclerosis pathology and therapy. Front Biosci 14:4477–4515CrossRef
42.
Kikuchi S, Fukazawa T, Niino M et al (2002) Estrogen receptor gene polymorphism and multiple sclerosis in Japanese patients: interaction with HLA-DRB1*1501 and disease modulation. J Neuroimmunol 128(1–2):77–81CrossRefPubMed
43.
Benešová Y, Vašků A, Štourač P et al (2013) Association of HLA-DRB1*1501 tagging rs3135388 gene polymorphism with multiple sclerosis. J Neuroimmunol 255(1–2):92–96CrossRefPubMed
44.
Čierny D, Hányšová S, Michalik J et al (2015) Genetic variants in interleukin 7 receptor α chain (IL-7Rα) are associated with multiple sclerosis risk and disability progression in Central European Slovak population. J Neuroimmunol 282:80–84CrossRefPubMed
45.
Weber F, Fontaine B, Cournu-Rebeix I et al (2008) IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations. Genes Immun 9:259–263CrossRefPubMed
46.
Zhang Z, Duvefelt K, Svensson F et al (2005) Two genes encoding immune-regulatory molecules (LAG3 and IL7R) confer susceptibility to multiple sclerosis. Genes Immun 6:145–152CrossRefPubMed
47.
Traggiai E, Biagioli T, Rosati E et al (2001) IL-7 enhanced T-cell response to myelin proteins in multiple sclerosis. J Neuroimmunol 121:111–119CrossRefPubMed
48.
Jäger J, Schulze C, Rösner S, Martin R (2013) IL7RA haplotype-associated alterations in cellular immune function and gene expression patterns in multiple sclerosis. Genes Immun 14:453–461CrossRefPubMed
49.
Traboulsee AL, Bernales CQ, Ross JP et al (2014) Genetic variants in IL2RA and IL7R affect multiple sclerosis disease risk and progression. Neurogenetics 15:165–169CrossRefPubMedPubMedCentral
50.
Zuvich RL, McCauley JL, Oksenberg JR, International Multiple Sclerosis Genetics Consortium, Aubin C, Cross AH, Piccio L et al (2010) Genetic variation in the IL7RA/IL7 pathway increases multiple sclerosis susceptibility. Hum Genet 127:525–535CrossRefPubMedPubMedCentral
51.
Mihailova S, Ivanova M, Mihaylova A et al (2005) Pro- and anti-infalmmatory cytokine gene polymorphism profiles in Bulgarian multiple sclerosis patients. J Neuroimmunol 168:138–143CrossRefPubMed
52.
Shahbazi M, Ebadi H, Fathi D et al (2010) HLA-DRB1*1501 intensifies the impact of IL-6 promoter polymorphism on the susceptibility to multiple sclerosis in an Iranian population. Mult Scler 16:1173–1176CrossRefPubMed
53.
54.
Schönrock LM, Gawlowski G, Brück W (2000) Interleukin-6 expression in human multiple sclerosis lesions. Neurosci Lett 10:45–48CrossRef
55.
Schulte-Herbrüggen O, Nassenstein C, Lommatzsch M et al (2005) Tumor necrosis factor-alpha and interleukin-6 regulate secretion of brain-derived neurotrophic factor in human monocytes. J Neuroimmunol 160:204–209CrossRefPubMed
56.
57.
Huang J, Yang Y, Zhou F et al (2016) Meta-analysis of the IL23R and IL12B polymorphisms in multiple sclerosis. Int J Neurosci 126:205–212CrossRefPubMed
58.
Javan MR, Shahraki S, Safa A et al (2017) An interleukin 12 B single nucleotide polymorphism increases IL-12p40 production and is associated with increased disease susceptibility in patients with relapsing–remitting multiple sclerosis. Neurol Res 39:4 35–441CrossRef
59.
Liu M, Hu X, Wang Y et al (2014) Association of IL-23 and its receptor gene single-nucleotide polymorphisms with multiple sclerosis in Chinese southern population. Int J Neurosci 124:904–907CrossRefPubMed
60.
Metadata
Title
Association of interleukin 6, interleukin 7 receptor alpha, and interleukin 12B gene polymorphisms with multiple sclerosis
Authors
Yvonne Benešová
Anna Vašků
Julie Bienertová-Vašků
Publication date
01-09-2018
Publisher
Springer International Publishing
Published in
Acta Neurologica Belgica / Issue 3/2018
Print ISSN: 0300-9009
Electronic ISSN: 2240-2993
DOI
https://doi.org/10.1007/s13760-018-0994-9

Other articles of this Issue 3/2018

Acta Neurologica Belgica 3/2018 Go to the issue

Original Article

Antibody profile may predict outcome in ocular myasthenia gravis

Original Article

Effects of ultrasound-guided botulinum toxin type-A injections with a specific approach in spastic cerebral palsy

Original Article

Migraine with aura and white matter tract changes

Original Article

Linguistic abilities in major vascular cognitive impairment: a comparative study with Alzheimer’s disease

Original Article

Microstructural changes in patients with Parkinson disease and REM sleep behavior disorder: depressive symptoms versus non-depressed

Original Article

The histopathological evaluation of small fiber neuropathy in patients with vitamin B12 deficiency